Japan is the world’s 3rd largest healthcare market and ranks amongst Europe’s top 5 pharmaceutical trading partners. With an unprecedented combination of increased longevity and declining birth rates, the Japanese market offers significant opportunities for innovative life science companies, novel technologies, services and products and can be a gateway to other Asian markets.
Get an insight into:
- the Japanese market, the authorities and other players in Japan
- the admission requirements and responsibilities
- options to find good and loyal local business partners and more …